INS and cancer: An illustrative example of therapeutic approaches with mild insulin-suppressing effects in cancer involves the use of sodium–glucose cotransporter 2 (SGLT2) inhibitors and/or the induction of a ketogenic state through lifestyle interventions, dietary changes, and the incorporation of medium-chain triglycerides [2].